Southwest Allergy and Asthma Associates
Southwest Allergy and Asthma Associates was paid $3.50M by Medicaid between Oct 2018 and Dec 2024, across 30 billing codes. Its largest line is 95004, Percutaneous tests with allergenic extracts, immediate type reaction — 22% of everything it billed.
33Billing provider infoSOUTHWEST ALLERGY AND ASTHMA ASSOCIATES
EL PASO, TX 79936
EL PASO, TX 79936
33aNPI1467563031assigned 08/31/2006
33bProvider typeSpecialist
28Total paid$3.50M
24GClaims62,200
24DCodes billed30
24AFirst – last monthOct 2018 – Dec 2024
Compared with peers
Next to other Specialist providers in Texas
Rank by total paid#12 of 382
Median peer was paid$29K
This provider vs. median121×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 23 | $145.54 | |
| 2019 | 12 | $368.78 | |
| 2020 | 2,246 | $146K | |
| 2021 | 11,297 | $750K | |
| 2022 | 13,383 | $1.04M | |
| 2023 | 17,898 | $966K | |
| 2024incomplete | 17,341 | $603K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 95004 | Percutaneous tests with allergenic extracts, immediate type reaction | 22% | 3,615 | 3,280 | $785K |
| J2357 | Injection, omalizumab, 5 mg | 21% | 484 | 321 | $737K |
| 95165 | Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, multiple dose vials | 19% | 2,657 | 1,903 | $679K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 18% | 11,941 | 10,466 | $633K |
| 99244 | Office or other outpatient consultation, moderate to high complexity | 5.4% | 1,507 | 1,438 | $189K |
| 95117 | 5.4% | 21,101 | 11,852 | $189K | |
| 96401 | 2.9% | 973 | 695 | $103K | |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 1.3% | 583 | 523 | $45K |
| 95115 | 1.0% | 4,907 | 2,784 | $36K | |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | <1% | 746 | 717 | $30K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | <1% | 337 | 303 | $17K |
| 94060 | <1% | 409 | 405 | $15K |
18 more codes
| 94729 | <1% | 292 | $13K | |
| 94726 | <1% | 293 | $12K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 132 | $6K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 545 | $6K |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 67 | $6K |
| 99243 | <1% | 27 | $3K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 42 | $557.93 |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 30 | $405.16 |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 13 | $36.36 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 16 | $15.79 |
| G8427 | Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | <1% | 4,080 | $1.58 |
| G8417 | Bmi is documented above normal parameters and a follow-up plan is documented | <1% | 1,015 | $0.53 |
| G8483 | Influenza immunization was not administered for reasons documented by clinician (e.g., patient allergy or other medical reasons, patient declined or other patient reasons, vaccine not available or other system reasons) | <1% | 1,864 | $0.01 |
| G8420 | Bmi is documented within normal parameters and no follow-up plan is required | <1% | 760 | $0.01 |
| G8482 | Influenza immunization administered or previously received | 0% | 863 | $0.00 |
| G8484 | Influenza immunization was not administered, reason not given | 0% | 1,156 | $0.00 |
| G8418 | Bmi is documented below normal parameters and a follow-up plan is documented | 0% | 1,511 | $0.00 |
| G8419 | Bmi documented outside normal parameters, no follow-up plan documented, no reason given | 0% | 234 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialVENZOR, JOSE (OWNER)